{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T11:07:53Z","timestamp":1775732873901,"version":"3.50.1"},"reference-count":53,"publisher":"Elsevier BV","issue":"20","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T00:00:00Z","timestamp":1728259200000},"content-version":"vor","delay-in-days":6,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005205","name":"Janssen Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005205","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008897","name":"Janssen Pharmaceutica","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008897","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.heliyon.2024.e39104","type":"journal-article","created":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T16:29:02Z","timestamp":1728491342000},"page":"e39104","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Middle-aged dogs with low and high A\u03b2 CSF concentrations show differences in energy and stress related metabolic profiles in CSF"],"prefix":"10.1016","volume":"10","author":[{"given":"Herman","family":"Borghys","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Schwab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4097-7775","authenticated-orcid":false,"given":"Brian","family":"Keppler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10284","key":"10.1016\/j.heliyon.2024.e39104_bib1","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","article-title":"Alzheimer's disease","volume":"397","author":"Scheltens","year":"2021","journal-title":"Lancet 24"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e39104_bib2","doi-asserted-by":"crossref","first-page":"795","DOI":"10.3233\/JAD181028","article-title":"Is alzheimer's disease risk modifiable?","volume":"67","author":"Serrano-Pozo","year":"2019","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e39104_bib3","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.3233\/JAD-2010-100573","article-title":"Acute effect on the A\u03b2 isoform pattern in CSF in response to \u03b3-secretase modulator and inhibitor treatment in dogs","volume":"21","author":"Portelius","year":"2010","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e39104_bib4","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0197-4580(00)00093-2","article-title":"Region-specific age at onset of beta-amyloid in dogs","volume":"21","author":"Head","year":"2000","journal-title":"Neurobiol. Aging"},{"issue":"9","key":"10.1016\/j.heliyon.2024.e39104_bib5","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1016\/j.bbadis.2013.03.016","article-title":"A canine model of human aging and Alzheimer's disease","volume":"1832","author":"Head","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"issue":"13","key":"10.1016\/j.heliyon.2024.e39104_bib6","doi-asserted-by":"crossref","first-page":"604","DOI":"10.3389\/fnins.2019.00604","article-title":"Canine cognitive dysfunction and alzheimer's disease - two facets of the same disease?","volume":"12","author":"Prpar Mihevc","year":"2019","journal-title":"Front. Neurosci."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e39104_bib7","doi-asserted-by":"crossref","first-page":"809","DOI":"10.3233\/JAD-2011-111475","article-title":"A canine model to evaluate efficacy and safety of \u03b3-secretase inhibitors and modulators","volume":"28","author":"Borghys","year":"2012","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e39104_bib8","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1523\/JNEUROSCI.4129-14.2015","article-title":"The potent BACE1 inhibitor LY2886721 elicits robust central A\u03b2 pharmacodynamic responses in mice, dogs, and humans","volume":"21","author":"May","year":"2015","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e39104_bib9","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3109\/08941939809098035","article-title":"Method for long-term cerebrospinal fluid collection in the conscious dog","volume":"11","author":"Wilsson-Rahmberg","year":"1998","journal-title":"J. Invest. Surg."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e39104_bib10","doi-asserted-by":"crossref","first-page":"126","DOI":"10.3390\/metabo11020126","article-title":"Metabolomics of cerebrospinal fluid from healthy subjects reveal metabolites associated with ageing","volume":"23","author":"Carlsson","year":"2021","journal-title":"Metabolites"},{"issue":"8","key":"10.1016\/j.heliyon.2024.e39104_bib11","doi-asserted-by":"crossref","DOI":"10.1002\/cti2.1318","article-title":"Cerebrospinal fluid metabolomics: detection of neuroinflammation in human central nervous system disease","volume":"6","author":"Yan","year":"2021","journal-title":"Clin Transl Immunology"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e39104_bib12","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3233\/JAD-191226","article-title":"Metabolic profiles help discriminate mild cognitive impairment from dementia stage in alzheimer's disease","volume":"74","author":"J\u00e4\u00e4skel\u00e4inen","year":"2020","journal-title":"J Alzheimers Dis"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e39104_bib13","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1292\/jvms.13-0520","article-title":"Gas chromatography-mass spectrometry-based metabolic profiling of cerebrospinal fluid from epileptic dogs","volume":"76","author":"Hasegawa","year":"2014","journal-title":"J. Vet. Med. Sci."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e39104_bib14","doi-asserted-by":"crossref","first-page":"763","DOI":"10.3233\/JAD-160434","article-title":"Young to middle-aged dogs with high amyloid-\u03b2 levels in cerebrospinal fluid are impaired on learning in standard cognition tests","volume":"56","author":"Borghys","year":"2017","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.heliyon.2024.e39104_bib15","article-title":"High resolution mass spectrometry improves data quantity and quality as compared to unit mass resolution mass spectrometry in high-throughput profiling metabolomics","volume":"4","author":"Evans","year":"2014","journal-title":"Metabolomics"},{"issue":"11","key":"10.1016\/j.heliyon.2024.e39104_bib16","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/S1474-4422(18)30318-1","article-title":"The glymphatic pathway in neurological disorders","volume":"17","author":"Rasmussen","year":"2018","journal-title":"Lancet Neurol."},{"issue":"7","key":"10.1016\/j.heliyon.2024.e39104_bib17","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1515\/revneuro-2020-0106","article-title":"The glymphatic system and meningeal lymphatics of the brain: new understanding of brain clearance","volume":"32","author":"Yankova","year":"2021","journal-title":"Rev. Neurosci."},{"issue":"10","key":"10.1016\/j.heliyon.2024.e39104_bib18","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1016\/j.bbapap.2016.06.007","article-title":"The world of protein acetylation","volume":"1864","author":"Drazic","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"issue":"7","key":"10.1016\/j.heliyon.2024.e39104_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-018-0116-z","article-title":"Spotlight on protein N-terminal acetylation","volume":"27","author":"Ree","year":"2018","journal-title":"Exp. Mol. Med."},{"issue":"17","key":"10.1016\/j.heliyon.2024.e39104_bib20","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1089\/ars.2016.6978","article-title":"Aspirin-mediated acetylation protects against multiple neurodegenerative pathologies by impeding protein aggregation","volume":"10","author":"Ayyadevara","year":"2017","journal-title":"Antioxid Redox Signal"},{"issue":"13","key":"10.1016\/j.heliyon.2024.e39104_bib21","doi-asserted-by":"crossref","first-page":"11612","DOI":"10.1074\/jbc.M210207200","article-title":"In vitro characterization of conditions for amyloid-beta peptide oligomerization and fibrillogenesis","volume":"28","author":"Stine","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/j.heliyon.2024.e39104_bib22","first-page":"1","article-title":"Protein modifications as manifestations of hyperglycemic glucotoxicity in diabetes and its complications","volume":"23","author":"Zheng","year":"2016","journal-title":"Biochem. Insights"},{"key":"10.1016\/j.heliyon.2024.e39104_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pneurobio.2015.05.001","article-title":"Impaired mitochondrial energy metabolism in Alzheimer's disease: impact on pathogenesis via disturbed epigenetic regulation of chromatin landscape","volume":"131","author":"Salminen","year":"2015","journal-title":"Prog Neurobiol"},{"issue":"6","key":"10.1016\/j.heliyon.2024.e39104_bib24","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1007\/s11064-016-2070-2","article-title":"Alterations in cerebral cortical glucose and glutamine metabolism precedes amyloid plaques in the APPswe\/PSEN1dE9 mouse model of alzheimer's disease","volume":"42","author":"Andersen","year":"2017","journal-title":"Neurochem. Res."},{"issue":"11","key":"10.1016\/j.heliyon.2024.e39104_bib25","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1038\/s41419-021-04237-y","article-title":"Hippocampal disruptions of synaptic and astrocyte metabolism are primary events of early amyloid pathology in the 5xFAD mouse model of Alzheimer's disease","volume":"16","author":"Andersen","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.heliyon.2024.e39104_bib26","article-title":"Astrocyte energy and neurotransmitter metabolism in Alzheimer's disease: integration of the glutamate\/GABA-glutamine cycle","volume":"21","author":"Andersen","year":"2022","journal-title":"Prog Neurobiol"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e39104_bib27","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.ymgme.2004.05.003","article-title":"Evaluation of pentitol metabolism in mammalian tissues provides new insight into disorders of human sugar metabolism","volume":"82","author":"Huck","year":"2004","journal-title":"Mol Genet Metab"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e39104_bib28","article-title":"The creatine kinase\/creatine connection to Alzheimer's disease: CK-inactivation, APP-CK complexes and focal creatine deposits","volume":"2006","author":"B\u00fcrklen","year":"2006","journal-title":"J. Biomed. Biotechnol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e39104_bib29","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1074\/jbc.C500244200","article-title":"Focally elevated creatine detected in amyloid precursor protein (APP) transgenic mice and Alzheimer disease brain tissue","volume":"6","author":"Gallant","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e39104_bib30","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1007\/s12640-011-9283-6","article-title":"Amyloid-\u03b2 production: major link between oxidative stress and BACE1","volume":"22","author":"Tamagno","year":"2012","journal-title":"Neurotox. Res."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e39104_bib31","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3390\/molecules23010191","article-title":"Mitochondria, oxidative stress and the kynurenine system, with a focus on ageing and neuroprotection","volume":"17","author":"Sas","year":"2018","journal-title":"Molecules"},{"issue":"7","key":"10.1016\/j.heliyon.2024.e39104_bib32","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.3390\/cells10071603","article-title":"Role of kynurenine pathway in oxidative stress during neurodegenerative disorders","volume":"26","author":"Mor","year":"2021","journal-title":"Cells"},{"issue":"1091","key":"10.1016\/j.heliyon.2024.e39104_bib33","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jchromb.2018.05.031","article-title":"Widely targeted metabolomics of Alzheimer's disease postmortem cerebrospinal fluid based on 9-fluorenylmethyl chloroformate derivatized ultra-high performance liquid chromatography tandem mass spectrometry","volume":"1","author":"Muguruma","year":"2018","journal-title":"Chromatogr B Analyt Technol Biomed Life Sci"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e39104_bib34","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1159\/000338546","article-title":"Plasma methionine sulfoxide in persons with familial Alzheimer's disease mutations","volume":"33","author":"Ringman","year":"2012","journal-title":"Dement. Geriatr. Cogn. Disord"},{"issue":"6","key":"10.1016\/j.heliyon.2024.e39104_bib35","doi-asserted-by":"crossref","first-page":"E388","DOI":"10.1152\/ajpendo.00453.2015","article-title":"Methionine sulfoxide reductase A affects \u03b2-amyloid solubility and mitochondrial function in a mouse model of Alzheimer's disease","volume":"15","author":"Moskovitz","year":"2016","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e39104_bib36","doi-asserted-by":"crossref","first-page":"775","DOI":"10.3390\/antiox11040775","article-title":"Protective effects against the development of alzheimer's disease in an animal model through active immunization with methionine-sulfoxide rich protein antigen","volume":"13","author":"Smith","year":"2022","journal-title":"J.Antioxidants"},{"issue":"Pt 1","key":"10.1016\/j.heliyon.2024.e39104_bib37","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.ijbiomac.2017.07.083","article-title":"Cysteine as a potential anti-amyloidogenic agent with protective ability against amyloid induced cytotoxicity","volume":"105","author":"Zaman","year":"2017","journal-title":"Int. J. Biol. Macromol."},{"issue":"28","key":"10.1016\/j.heliyon.2024.e39104_bib38","doi-asserted-by":"crossref","first-page":"9878","DOI":"10.1021\/acs.analchem.1c01945","article-title":"Direct quantification and visualization of homocysteine, cysteine, and glutathione in alzheimer's and Parkinson's disease model tissues","volume":"20","author":"Yin","year":"2021","journal-title":"Anal. Chem."},{"key":"10.1016\/j.heliyon.2024.e39104_bib39","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.brainresbull.2017.04.001","article-title":"Influence of N-acetyl cysteine on beta-amyloid-induced Alzheimer's disease in a rat model: a behavioral and electrophysiological study","volume":"131","author":"Shahidi","year":"2017","journal-title":"Brain Res. Bull."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e39104_bib40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0090671","article-title":"Differential neuroprotective effects of 5'-deoxy-5'-methylthioadenosine","volume":"5","author":"Moreno","year":"2014","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e39104_bib41","doi-asserted-by":"crossref","first-page":"927","DOI":"10.7150\/jca.27160","article-title":"5'-Methylthioadenosine and Cancer: old molecules, new understanding","volume":"29","author":"Li","year":"2019","journal-title":"J. Cancer"},{"issue":"5","key":"10.1016\/j.heliyon.2024.e39104_bib42","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1002\/hep.31907","article-title":"Admission urinary and serum metabolites predict renal outcomes in hospitalized patients with cirrhosis","volume":"74","author":"Bajaj","year":"2021","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.heliyon.2024.e39104_bib43","doi-asserted-by":"crossref","first-page":"319","DOI":"10.2174\/138920310791330668","article-title":"Lipid membranes and beta-amyloid: a harmful connection","volume":"11","author":"Eckert","year":"2010","journal-title":"Curr. Protein Pept. Sci."},{"issue":"13","key":"10.1016\/j.heliyon.2024.e39104_bib44","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3389\/fncel.2019.00309","article-title":"Alzheimer's disease as a membrane disorder: spatial cross-talk among beta-amyloid peptides, nicotinic acetylcholine receptors and lipid rafts","volume":"18","author":"Fabiani","year":"2019","journal-title":"Front. Cell. Neurosci."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e39104_bib45","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1083\/jcb.200207113","article-title":"Amyloidogenic processing of the Alzheimer beta-amyloid precursor protein depends on lipid rafts","volume":"6","author":"Ehehalt","year":"2003","journal-title":"Cell Biol."},{"issue":"10","key":"10.1016\/j.heliyon.2024.e39104_bib46","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.3390\/cells10102591","article-title":"Lipid profiling of alzheimer's disease brain highlights enrichment in glycerol(phospho)lipid, and sphingolipid metabolism","volume":"10","author":"Akyol","year":"2021","journal-title":"Cells"},{"issue":"5","key":"10.1016\/j.heliyon.2024.e39104_bib47","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1097\/MOL.0000000000000334","article-title":"Intestinal phospholipid and lysophospholipid metabolism in cardiometabolic disease","volume":"27","author":"Hui","year":"2016","journal-title":"Curr. Opin. Lipidol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e39104_bib48","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/s13195-018-0451-2","article-title":"The gut microbiota-derived metabolite trimethylamine N-oxide is elevated in Alzheimer's disease","volume":"22","author":"Vogt","year":"2018","journal-title":"Alzheimer's Res. Ther."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e39104_bib49","first-page":"2390","article-title":"From Myo-inositol to D-chiro-inositol molecular pathways","volume":"25","author":"Kiani","year":"2021","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"19","key":"10.1016\/j.heliyon.2024.e39104_bib50","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1212\/WNL.0000000000002672","article-title":"Myo-inositol changes precede amyloid pathology and relate to APOE genotype in Alzheimer disease","volume":"10","author":"Voevodskaya","year":"2016","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e39104_bib51","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1159\/000088196","article-title":"Purine and pyrimidine metabolism and electrocortical brain activity during hypotension in near-term lambs","volume":"89","author":"Van Os","year":"2006","journal-title":"Biol. Neonate"},{"issue":"7","key":"10.1016\/j.heliyon.2024.e39104_bib52","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202200509R","article-title":"Cerebrospinal fluid and plasma metabolomics of acute endurance exercise","volume":"36","author":"Li","year":"2022","journal-title":"FASEB J"},{"key":"10.1016\/j.heliyon.2024.e39104_bib53","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jpba.2014.10.009","article-title":"Metabolomic screening of regional brain alterations in the APP\/PS1 transgenic model of Alzheimer's disease by direct infusion mass spectrometry","volume":"102","author":"Gonz\u00e1lez-Dom\u00ednguez","year":"2015","journal-title":"J. Pharm. Biomed. Anal."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024151353?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024151353?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T10:24:47Z","timestamp":1775730287000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844024151353"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":53,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S2405844024151353"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e39104","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Middle-aged dogs with low and high A\u03b2 CSF concentrations show differences in energy and stress related metabolic profiles in CSF","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e39104","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e39104"}}